Fat Loss & Metabolism

-33%

AOD-9604 10mg research peptide vial - Modified HGH Fragment - ReVICO Labs Canada

Hot Sale 33% off.

5-Amino-1-MQ 50mg Canada | NNMT Research Compound | ReVICO Labs

5-Amino-1-MQ 50mg Canada is a small-molecule NNMT research compound supplied in a sealed 50mg vial for controlled laboratory research use only.

Quick Add

Compare

Quick View

-37%

AOD-9604 10mg vial - Modified HGH Fragment research peptide - ReVICO Labs Canada

Hot Sale 37% off.

AOD-9604 10mg Canada | Modified HGH Fragment | ReVICO Labs

AOD-9604 10mg Canada is a lyophilized research peptide supplied in a sealed vial for controlled laboratory use. Also known as Modified HGH Fragment 176-191, it is commonly studied in metabolic, lipid-signaling and adipose-tissue research.

Quick Add

Compare

Quick View

-29% Hot

Hot Sale 29% off.

MOTS-c (30mg)

MOTS-c is a mitochondrial-derived peptide being studied for energy regulation, endurance, and metabolic health.

Research Summary: Mitochondrial peptide studied for metabolic regulation, insulin sensitivity, and exercise performance.

Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.

Quick Add

Compare

Quick View

-50%

Hot Sale 50% off.

Retatrutide (10mg)

Retatrutide is a triple agonist peptide showing promise in clinical studies for advanced fat loss and metabolic health.

Research Summary: Triple agonist (GLP-1/GIP/Glucagon) studied for weight loss and glucose control. Under clinical investigation for obesity and metabolic dysfunction.

Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.

Quick Add

Compare

Quick View

-50%

Hot Sale 50% off.

Retatrutide 20mg

Retatrutide is a triple agonist peptide showing promise in clinical studies for advanced fat loss and metabolic health.

Research Summary: Triple agonist (GLP-1/GIP/Glucagon) studied for weight loss and glucose control. Under clinical investigation for obesity and metabolic dysfunction.

Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.

Quick Add

Compare

Quick View

-55%

Hot Sale 55% off.

Semaglutide (5mg)

GLP-1 receptor agonist studied in obesity and diabetes research models.

Research Summary: GLP-1 receptor agonist studied in obesity and diabetes research models.

Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.

Quick Add

Compare

Quick View

-55%

Hot Sale 55% off.

Tirzepatide (20mg)

Dual GIP/GLP-1 agonist under investigation for glycemic regulation and adiposity control.

Research Summary: Dual GIP/GLP-1 agonist under investigation for glycemic regulation and adiposity control.

Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.

Quick Add

Compare

Quick View

-55%

Tirzepatide 10mg peptide vial - ReVICO Labs Canada

Hot Sale 55% off.

Tirzepatide 10mg

Dual GIP/GLP-1 agonist under investigation for glycemic regulation and adiposity control.

Research Summary: Dual GIP/GLP-1 agonist under investigation for glycemic regulation and adiposity control.

Legal Notice: FOR RESEARCH PURPOSES ONLY. Not for human or veterinary administration. Not intended for therapeutic, diagnostic, or dietary use. Sold exclusively for laboratory research by qualified professionals.

Quick Add

Compare

Quick View